A non-invasive and cost-effective method of analysis, urinalysis or urine test is a potential tool for physicians to detect and manage disorders such as urinary tract infections (UTIs), liver disease, kidney disease, and diabetes. According to a research report from Market Research Future, the global urinalysis test market is expected to grow at a CAGR of 6.3% during the forecast period from 2017-2023. Urinalysis analyzers of advanced types are now available and most of them can be now integrated with Electronic Health Records (EHR) to directly link the results into the patient's database. For example, Siemens DCA Vantage analyzer and Clinitek Status point-of-care (POC) instruments have cloud-based connectivity which will send patient test results automatically from these POC instruments to physician-office EHR systems.
Key factors expected to drive the growth of this global market include:
- increasing demand for point-of-care testing devices
- rising prevalence of chronic diseases
- developing technology in the field of diagnostics
- cost-effectiveness of the test
- higher demand for automated urine analyzers
However, the growth of this market will be impacted by the lack of trained professionals and stringent regulations governing the manufacturing and sales of chemistry analyzers across the globe.
The global urinalysis test market is classified on the basis of product type, test type, application, and end user.
Product types in the market are categorized into instruments and consumables. While the instruments type includes urine chemistry analyzers such as automatic urine analyzers and semi-automatic urine analyzers, automated urine sediment analyzers, point-of-care devices, and strip analyzer; consumables include plastic consumables, test strips, and chemical agents.
Based on test type, the market is segmented into macroscopic urinalysis, biochemical urinalysis, and sediments/microscopic urinalysis. Application segment includes diagnosis of diseases such as kidney disease, liver disease, diabetes, pregnancy tests, and others. End users are hospitals, independent laboratories, and physician practices.
Region wise, the Americas is the largest market for urinalysis test owing to the rising demand for automated urine analyzers, technological advancements, and rising prevalence of kidney and liver diseases. In North America, the U.S. holds the largest share of the global market owing to the concentration of the major players manufacturing urine analyzers and consumables across the globe.
Key manufacturers in this market include Beckman Coulter, F. Hoffmann-La Roche Ltd, ACON Laboratories, Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., ARKRAY, Inc., and Siemens AG.